WallStreetZenWallStreetZen

NASDAQ: ALGS
Aligos Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their ALGS stock forecasts and price targets.

Forecast return on equity

Is ALGS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is ALGS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ALGS revenue forecast

What is ALGS's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$122.0M+685.63%
Avg 2 year Forecast
$322.1M+1,973.89%
Avg 3 year Forecast
$599.7M+3,761.48%
ALGS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALGS revenue growth forecast

How is ALGS forecast to perform vs Biotechnology companies and vs the US market?
Company
235.91%
Industry
37.5%
Market
10.08%
ALGS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALGS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALGS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ALGS$0.83N/AN/A
THTX$1.36N/AN/A
EQ$1.79$5.00+179.33%Buy
IKNA$1.29$9.50+636.43%Buy
CLGN$5.41$11.00+103.33%Buy
View Top Biotech Stocks

Aligos Therapeutics Stock Forecast FAQ

What is ALGS's revenue growth forecast for 2027-2029?

(NASDAQ: ALGS) Aligos Therapeutics's forecast annual revenue growth rate of 235.91% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Aligos Therapeutics's revenue in 2024 is $15,529,000.On average, 1 Wall Street analysts forecast ALGS's revenue for 2027 to be $9,231,559,562, with the lowest ALGS revenue forecast at $9,231,559,562, and the highest ALGS revenue forecast at $9,231,559,562. On average, 2 Wall Street analysts forecast ALGS's revenue for 2028 to be $24,369,425,531, with the lowest ALGS revenue forecast at $18,085,533,204, and the highest ALGS revenue forecast at $30,653,317,857.

In 2029, ALGS is forecast to generate $45,374,628,618 in revenue, with the lowest revenue forecast at $38,802,817,569 and the highest revenue forecast at $51,946,439,667.

If you're new to stock investing, here's how to buy Aligos Therapeutics stock.

What is ALGS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ALGS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ALGS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ALGS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.